1
|
Abstract
Lung squamous carcinoma (LUSC) is the second most frequent subtype of non-small cell lung cancer. Rarely gene alterations are identified in LUSC. Therefore, identifying LUSC-related genes to explain the relevant molecular mechanism is urgently needed. A potential biomarker, calcium-activated nucleotidase 1 (CANT1), was elevated in tissues of LUSC patients relative to normal cases based on the TCGA and/or GTEx database. CCK-8 and transwell tests were then implemented to measure the proliferative, invasive and migratory capacities, and showed that knockdown of CANT1 blocked LUSC cells proliferation. miR-607, predicted as an upstream factor for CANT1, was declined in LUSC using TargetScan analysis and luciferase activity test. Low miR-607 expression was related with unfavorable outcomes of LUSC patients. Moreover, miR-607 downregulation elevated cell viability, invasion and migration in LUSC cells, which was antagonized by si-CANT1. GEPIA website was accessed to estimate the relevance between CANT1 and epithelial-mesenchymal transition (EMT)-related positive factors. The protein levels of Fibronectin, Vimentin, Snail and β-catenin were altered due to the abnormal CANT1 and miR-607 expression. Together, these data unveiled that miR-607/CANT1 pair may exert a vital role in the progression of LUSC through mediating EMT process, which would furnish an available therapeutic therapy for LUSC.
Collapse
Affiliation(s)
- Gang Qiao
- Department of Integrative Medicine Oncology, Zibo Bashan Wanjie Hospital, Zibo
| | - Hai-Bo Wang
- Emergency department, Rizhao Central Hospital, Rizhao
| | - Xiu-Na Duan
- Department of Nuclear Medicine, Central Hospital of Shan County, Shan County, Heze, Shandong People's Republic of China
| | - Xiao-Fang Yan
- Department of Nuclear Medicine, Central Hospital of Shan County, Shan County, Heze, Shandong People's Republic of China
| |
Collapse
|
2
|
Bai YG, Xu L, Duan XN, Liu YH, Ye JM, Liu Q, Cheng YJ, Xin L, Wang LH, Bao HL, Yu ZG, Liu LY, Wang R, Shi ZG. [The Breast Cancer Cohort Study in Chinese Women: research design and preliminary results of clinical multi-center cohort]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 41:2046-2052. [PMID: 33378815 DOI: 10.3760/cma.j.cn112338-20200507-00694] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: The incidence of breast cancer in Chinese women continues to rise. The large breast cancer cohort studies in China are relatively scarce. There are many bottlenecks in the construction of large clinical cohort for breast cancer diagnosis, treatment, and prognoses, such as inconsistent standards, high rates of lost follow-up, repeated construction, and inability to share. To better solving the difficulties and problems faced by large-scale clinical cohort research in China, this project will cooperate with several tertiary A hospitals to establish a breast cancer cohort in Chinese women. It also provides a data platform and technical support for breast cancer multi-center clinical cohort research. Methods: Based on the evidence-based medicine and expert opinion and consensus, we established a breast cancer cohort standardized indicator set-recording baseline information, diagnosis and treatment-related information of the enrolled patients, and collecting biological specimens. According to the technical specification of long-term follow-up for the endpoint, data management, and data security and in the large population-based cohort study, a standardized follow-up system for the diagnosis, treatment, and prognosis of breast cancer prospective cohorts is formed. Results: Based on standardized data sets and the computer discipline's advantage from the University of Science and Technology Beijing, we integrate the new information technology methods, including dynamic information collection terminals and social networks. Thus, the quality of control programs on compliance and intelligence data was improved, and a Chinese women breast cancer cohort database was developed. By February 2020, 12 147 patients were included in the clinical cohort database. Biological specimens'resources in cohort construction were collected and cooperated with Shandong University to research the multi-center quality control system and shared evaluation system of biobanks. Building an open and shared biobank network and forming a full chain of breast cancer research platform. Conclusion: With the implementation of the "13(th) Five-Year Plan" precision medicine research, this study provides a research foundation for precision diagnosis and treatment of breast cancer and provides data support for the country to formulate relevant medical policies.
Collapse
Affiliation(s)
- Y G Bai
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - L Xu
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - X N Duan
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - Y H Liu
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - J M Ye
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - Q Liu
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - Y J Cheng
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - L Xin
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - L H Wang
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - H L Bao
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Z G Yu
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - L Y Liu
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - R Wang
- University of Science and Technology Beijing, Beijing 100083, China
| | - Z G Shi
- University of Science and Technology Beijing, Beijing 100083, China
| |
Collapse
|
3
|
Cai H, Liu LY, Wang F, Bao HL, Yu ZG, Wang LH, Fang LW, Xu L, Wang R, Huangfu W, Ye CM, Yin GS, Duan XN, Jia HY. [The Breast Cancer Cohort Study in Chinese Women: the construction and progress of the pan-shared biobank]. Zhonghua Liu Xing Bing Xue Za Zhi 2021; 41:2053-2058. [PMID: 33378816 DOI: 10.3760/cma.j.cn112338-20200507-00697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: Biobank construction plays an irreplaceable role in the research of accurate prevention and treatment of diseases. Shared biobank network based on a large crowd queue is the way of the future. This subject is one of the key contents of national precision medicine "The Breast Cancer Cohort Study in Chinese Women: (BCCS-CW)" , aiming to solve the bottleneck of insufficient standardization and sharing. Methods: The establishment of "entity library-information library-extension library" , the widely Shared network of biobank of breast cancer specific disease cohort, and the establishment of strict standard setting and quality control standard to construct the standardized biobank. Results: This biobank provides a shared biobank resource for breast cancer risk assessment, prediction and early warning, early screening, classification, individualized treatment, efficacy and safety prediction and monitoring and other accurate prevention and treatment programs and clinical decision-making system research. Conclusion: The data of this biological sample bank is refined and complete, and the sample size of cases is sufficient, which can meet the research needs of medical big data, genomics, metabonomics, epigenetics and other fields.
Collapse
Affiliation(s)
- H Cai
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - L Y Liu
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - F Wang
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - H L Bao
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Z G Yu
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - L H Wang
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - L W Fang
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - L Xu
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - R Wang
- University of Science and Technology Beijing, Beijing 100083, China
| | - W Huangfu
- University of Science and Technology Beijing, Beijing 100083, China
| | - C M Ye
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - G S Yin
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - X N Duan
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - H Y Jia
- The Second Hospital of Shandong University, Ji'nan 250033, China
| |
Collapse
|
4
|
Bao HL, Liu LY, Fang LW, Cong S, Fu ZT, Tang JL, Yang S, Shi WW, Fan M, Cao MQ, Guo XL, Sun JX, Geng CZ, Duan XN, Yu ZG, Wang LH. [The Breast Cancer Cohort Study in Chinese Women: the methodology of population-based cohort and baseline characteristics]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:2040-2045. [PMID: 33378814 DOI: 10.3760/cma.j.cn112338-20200507-00695] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: Breast cancer has been the first cancer among women with the incidence increasing gradually. In September 2016, the Breast Cancer Cohort Study in Chinese Women (BCCS-CW) was initiated, aiming to establish a standardized and sharable breast cancer-specific cohort by integrating the existing cohort resource and improving the quality of follow-up. The BCCS-CW may provide a research basis and platform for the precision prevention and treatment of breast cancer in etiology identification, prevention, early diagnosis, treatment, and prognosis prediction. Methods: We conducted a population-based perspective cohort by questionnaire interview, anthropometry, biological specimens, breast ultrasound and mammography. The cohort was followed by using regional health surveillance and ad hoc survey. Results: Finally, BCCS-CW included 112 118 women, in which 55 419 women completed the standardized investigation and blood specimens were collected from 54 304 women. The mean age of participants was 51.7 years old, 62.7% were overweight or obese, and 48.9% were menopausal. Conclusion: The BCCS-CW will provide population-based cohort resource and research platform for the precise prevention and treatment of breast cancer in Chinese women.
Collapse
Affiliation(s)
- H L Bao
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - L Y Liu
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - L W Fang
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - S Cong
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Z T Fu
- Shandong Center for Disease Control and Prevention, Ji'nan 250014, China
| | - J L Tang
- Shandong Center for Disease Control and Prevention, Ji'nan 250014, China
| | - S Yang
- The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang 050019, China
| | - W W Shi
- Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China
| | - M Fan
- Taixing Center for Disease Control and Prevention, Taizhou 225400, China
| | - M Q Cao
- Taixing Center for Disease Control and Prevention, Taizhou 225400, China
| | - X L Guo
- Shandong Center for Disease Control and Prevention, Ji'nan 250014, China
| | - J X Sun
- Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China
| | - C Z Geng
- The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang 050019, China
| | - X N Duan
- Breast Disease Center, Peking University First Hospital, Beijing 100034, China
| | - Z G Yu
- The Second Hospital of Shandong University, Ji'nan 250033, China
| | - L H Wang
- National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| |
Collapse
|
5
|
Sun Y, Fang J, Yang R, Lai YP, Hu JJ, Duan XN, Su PY, Wan YH, Tao FB. [Prospective association between early adiposity rebound and adolescent development in girls]. Zhonghua Yu Fang Yi Xue Za Zhi 2019; 51:796-800. [PMID: 28881544 DOI: 10.3760/cma.j.issn.0253-9624.2017.09.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To determine possible relations between early adiposity rebound and adolescent development. Methods: Prospective children cohort from 2 kindergartens selected through clustering convenience sampling method in Anhui Province was established since Sep. 2010. Participants were classified as Cohort 1 (2010), Cohort 2 (2011) and Cohort 3 (2012) according to the recruiting year. Till Sep. 2015, a toal of 802 girls were included in this study, and received follow-up till primary school. During kindergarten period, physical examination was carried out every 3 months, 8 times in total. In primary school, physical examination was carried out annually; till Sep.2015, the cohort 1, 2, 3 took physical examination for 12, 11, 10 times, respectively. Information on household economic status and child physical activity was acquired through parents questionnaire survey, and breast development were assessed through visual inspection and palpation. Adiposity rebound was determined according to Rolland-Cachera's method for each girl. Differences between early adiposity rebound and normal adiposity rebound groups were compared by using t test and χ(2) test. Multivariate regression analysis was applied to explore the association between early adiposity rebound and breast development. Results: The average age of participants was (8.90±0.87) years old and the BMI was (17.48±2.70) kg/m(2). The average age at adiposity rebound was (6.16±0.90) years old and the BMI was (15.33±1.82) kg/m(2). Premature breast development was found significantly higher in girls in early adiposity rebound group (27.8%, 54/802) than it in normal adiposity rebound group (13.7%) (P<0.001). After current adiposity, age, household economic status, childhood physical activity adjusted, the OR of premature beast development in early adiposity rebound group was 2.41(95%CI: 1.41-4.12). Conclusion: Early adiposity rebound increases the risk of premature puberty in girls.
Collapse
Affiliation(s)
- Y Sun
- Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei 230032, China
| | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Xu L, Ye JM, Zhu SN, Zhao JY, Xin L, Cheng YJ, Liu Q, Zhang H, Zhang S, Duan XN, Liu YH. [Analysis of neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) in HER-2-positive breast cancer]. Zhonghua Yi Xue Za Zhi 2018; 98:907-911. [PMID: 29665663 DOI: 10.3760/cma.j.issn.0376-2491.2018.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze docetaxel (T) and carboplatin (C) combined with trastuzumab (H) -TCH regimen as neoadjuvant systemic therapy in early breast cancer patients with human epidermal growth factor receptor 2 (HER-2) positive. Methods: From January 2008 to December 2014, the data of patients diagnosed as early breast cancer in Breast Disease Center of Peking University First Hospital were retrospective reviewed. The data of patients with HER-2 positive conducted TCH neoadjuvant therapy and surgery, and with the complete clinicopathological information were analyzed. Results: A total of 77 cases were enrolled in this study. We defined G2+ G3+ G4+ G5 as responsive group according to Miller-Payne grading system, the responsive rate was 84.4% (65/77). The rate of complete pathological remission (pCR) was 39.0% (30/77). The 5-year disease free survival (DFS) was 87.3%, and 5-year overall survival (OS) was 93.6%. There was a significant difference between DFS and OS in the responsive group and non-responsive group (DFS: χ2=6.762, P=0.009; OS: χ2=5.062, P=0.024). Conclusion: TCH is an effective neoadjuvant therapy for patients with HER-2 positive breast cancer, and the toxic and side effects were under control.
Collapse
Affiliation(s)
- L Xu
- The Breast Disease Center of Peking University First Hospital, Beijing 100034, China
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Gong C, Fang J, Shan J, Duan XN, Hu JJ, Chen HR, Zhang JJ, Wan YH, Sun Y. [Prospective association between childhood abuse experiences and depressive symptoms in adolescence]. Zhonghua Liu Xing Bing Xue Za Zhi 2018; 39:1184-1187. [PMID: 30293307 DOI: 10.3760/cma.j.issn.0254-6450.2018.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the prospective association between childhood abuse experiences and depressive symptoms in adolescence. Methods: Students in grade 3 and 4 from three primary schools were selected, with informed consent, through convenience cluster sampling in Bengbu, Anhui province in May 2013. The students' body height, weight were assessed. Childhood abuse experiences including emotional, physical or sexual abuses, as well as depressive symptoms were reported by children themselves. Data on parental educational background and household economic status were collected through parent questionnaire. A follow up was conducted 4 years later after baseline survey. Depressive symptoms were evaluated by using Children's Depression Inventory at baseline survey, and by using Mood and Feeling Questionnaire at follow-up. Logistic regression model was used to analyze the relationship between childhood abuse experiences and depressive symptoms in adolescence. Results: A total of 1 172 students were included in baseline survey, and a follow-up was conducted for 87.1% of them (n=1 021). Among 1 126 students with complete information on childhood abuse experiences at baseline survey, the reported rates of physical, emotional and sexual abuses were 12.8% (144/1 126), 11.1% (125/1 126) and 10.9% (123/1 126), respectively. The prevalence of depressive symptoms at baseline survey and follow-up was 7.0% (82/1 172) and 12.3% (126/1 021), respectively. After adjusted for baseline depressive symptoms, age at follow-up, sex, the only-child in family, household economic status, divorce of parents and BMI, childhood emotional and physical abuse experiences were significant risk factors for depressive symptoms in mid-adolescence, with the ORs were 1.86 (95%CI: 1.03-3.36, P=0.039) and 2.37 (95%CI: 1.39-4.03, P=0.001), respectively. Conclusion: Childhood physical and emotional abuse might increase the risk of depressive symptoms in adolescence.
Collapse
Affiliation(s)
- C Gong
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - J Fang
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - J Shan
- Bengbu Gaoxin Experimental School, Bengbu 233000, China
| | - X N Duan
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - J J Hu
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - H R Chen
- Chinese Journal of School Health, Bengbu 233000, China
| | - J J Zhang
- The First Affiliated Hospital of University of Science and Technology of China, Hefei 230000, China
| | - Y H Wan
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, China
| | - Y Sun
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei 230032, China
| |
Collapse
|
8
|
Duan XN, Yan SQ, Wang SM, Hu JJ, Fang J, Gong C, Wan YH, Su PY, Tao FB, Sun Y. [Developmental characteristics of circadian rhythms in hypothalamic-pituitary-adrenal axis during puberty]. Zhonghua Liu Xing Bing Xue Za Zhi 2018; 39:1086-1090. [PMID: 30180433 DOI: 10.3760/cma.j.issn.0254-6450.2018.08.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the developmental characteristics of circadian rhythms in hypothalamus-pituitary-adrenal (HPA) axis during puberty. Methods: A total of 1 070 students from Grade 2-3 in 3 primary schools in Ma'anshan city, Anhui province, were selected for physical examination and circadian rhythm of HPA axis checked from 2015 to 2017. Saliva samples were collected at each of the following three time points: immediately upon wakening, 30 minutes after wakening and bedtime, with the index of circadian rhythm of HPA axis calculated, which including cortisol awake response (CAR), cortisol in puberty priming and diurnal cortisol slope (DCS). Testicular volume, palpation and visual inspection of breast development were used to assess the state of purbety development on boys and girls. Information on gender, date of birth, time to fall asleep, wake-up time and weekly physical activity were gathered through questionnaire survey. Non-parametric test was used to compare the differences of baseline, follow-up period and different adolescent developmental processes of each index on circadian rhythm of HPA axis. Results: During the period of follow-up program and comparing with the continuous undeveloped group, CAR and the changes of CAR showed significantly increase, both in the puberty priming group and continuous development group, with statistically significant differences (CAR: Z=8.551, 4.680, respectively; P<0.01; the changes of CAR: Z=4.079, 2.700, respectively, P<0.01). There were no significant differences noticed in CAR and the changes of CAR between puberty priming group or continuous development group. The area under the curve (AUC) of cortisol in puberty priming group was slightly higher than that in the persistent undeveloped group (Z=2.591, P=0.010). Both the changes of daily cortisol slope (DCS) in puberty priming group and continuing developed group decreased significantly, when comparing with those in continuous undeveloped group (Z=-2.450, Z=-2.151; all P<0.05). There was no significant difference noticed in the changes of cortisol in puberty priming and DCS between different puberty development stages (the changes of AUC: χ(2)=2.747, P=0.253; DCS: χ(2)=4.554, P=0.032). Conclusions: The indexes of circadian rhythm of HPA axis were associated with the development of puberty. Both the cortisol awakening response and the total amount of diurnal cortisol secretion showed an increase, along with the puberty development. The change of diurnal cortisol slope declined with the development of puberty.
Collapse
Affiliation(s)
- X N Duan
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - S Q Yan
- Ma'anshan Maternal and Child Health Center, Ma'anshan 243011, China
| | - S M Wang
- Ma'anshan Maternal and Child Health Center, Ma'anshan 243011, China
| | - J J Hu
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - J Fang
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - C Gong
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - Y H Wan
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - P Y Su
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - F B Tao
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| | - Y Sun
- Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Anhui Provincial Key Laboratory of Population Health and Aristogenics, Hefei 230032, China
| |
Collapse
|
9
|
Hu JJ, Duan XN, Fang J, Xu N, Wan YH, Su PY, Tao FB, Sun Y. [Association between hair cortisol concentration and overweight and obesity in 6-9 years old childhood]. Zhonghua Yu Fang Yi Xue Za Zhi 2017; 51:1065-1068. [PMID: 29262485 DOI: 10.3760/cma.j.issn.0253-9624.2017.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To determine the possible relations between hair cortisol concentration (HCC) as a biomarker of chronic stress and childhood overweight and obesity. Methods: Children from grade 1 to 3 from 2 primary schools in Bengbu were invited to participate in the study; and those who suffer from mental disorders, endocrine diseases and those who took hormone drugs were excluded. Parental questionnaire was implemented to collect information on physical activity, screen time, sleep duration, sugar-beverage consumption, as well as socio-economic status. Height and weight were examined. Eligible hair samples from 1 263 children (598 boys and 665 girls) were obtained, and the cortisol content was determined. Multivariate logistic regression model analysis was recruited to examine the association between HCC quartiles and overweight and obesity among boys and girls, respectively. Results: HCC in P(50) (P(25)-P(75)) among girls and boys was separately 11.86 (10.57-13.15) and 11.71 (10.54-13.09) µg/kg (Z=-0.886, P=0.376); HCC in P(50) (P(25)-P(75)) among non-overweight, overweight and obesity boys was separately 11.62 (10.45-12.82), 12.24 (10.88-13.55) and 12.30 (10.99-13.53) µg/kg (χ(2)=8.24, P=0.016); HCC in P(50) (P(25)-P(75)) among non-overweight, overweight and obesity girls was separately 11.35 (10.06-12.62), 12.07 (11.04-13.21) and 12.59 (11.12-13.63) µg/kg (χ(2)=36.16, P<0.001). After age, physical activity, screen time, sleep duration, sugared beverages and socio-economic status adjusted, compared with HCC in Q1 level, girls whose HCC in Q2, Q3 Q4 level had higher rates in overweight, with OR (95%CI) at 1.10 (1.04-3.32), 2.59 (1.51-4.45) and 3.16 (1.79-5.57), respectively. Girls with HCC in Q3 and Q4 level had higher rates in obesity, with OR (95%CI) at 2.22 (1.16-4.26) and 5.62 (3.04-10.41). Among boys, highest quartiles in HCC was risk factor for overweight, OR (95%CI) was 2.14 (1.18-3.90). Conclusion: Hair cortisol had a significant relation with overweight and obesity in 6-9 years old childhood especially among girls.
Collapse
Affiliation(s)
- J J Hu
- School of Public Health, Anhui Medical University, Hefei 230032, China
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Duan XN, Sun Y. [Developmental pattern of hypothalamic-pituitary-adrenal axis during pubertal transition and implications for emotional disorders]. Zhonghua Yu Fang Yi Xue Za Zhi 2017; 51:865-869. [PMID: 28881558 DOI: 10.3760/cma.j.issn.0253-9624.2017.09.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
During an individual's life, puberty is not only a crucial phase for physical development, but a key period for neuroendocrine transformation. As a major neuroendocrine axis, the influence of hypothalamic-pituitary-adrenal (HPA) axis's changes during puberty on mental and physical health, as well as emotional symptoms, is causing a growing attention. However, information of its developing pattern and circadian variation is limited. Recent research has demonstrated that certain developing pattern of HPA axis in puberty is closely related to the adolescent emotional disorders, which highlights the recognition of HPA functions developing paths under both resting and stress state and the evaluation of its prediction effect for the adolescent emotional disorders. Generally, cortisol awakening response is utilised to assess HPA functions. Elaborating the variation of HPA axis functions from the puberty to the later developing process provides much guiding significance for the early screening, intervention and treatment of adolescent emotional disorders.
Collapse
Affiliation(s)
- X N Duan
- Department of Maternal, Child & Adolescent Health, School of Public Health, Anhui Medical University; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei 230032, China
| | | |
Collapse
|
11
|
Cong S, Fang LW, Bao HL, Feng YJ, Wang N, Yin P, Li YC, Duan XN, Zhou MG. [Disease burden of thyroid cancer in the Chinese population, in 1990 and 2013]. Zhonghua Liu Xing Bing Xue Za Zhi 2017; 37:773-7. [PMID: 27346100 DOI: 10.3760/cma.j.issn.0254-6450.2016.06.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
OBJECTIVE To analyze the disease burden of thyroid cancer in the Chinese population, in 1990 and 2013. METHODS Data on China from the Global Burden of Disease 2013 (GBD2013) was used to analyze the related parameters as mortality, prevalence,years of life lost due to premature mortality (YLL), years lived with disability (YLD) and disability-adjusted life years (DALY) of thyroid cancer in China in 1990 and 2013 among all the Chinese population. RESULTS There were 33 939 thyroid cancer patients identified in 2013 (7 146 men and 26 793 women), with an increase of 21 898 patients than the number in 1990. The incidence rate of thyroid cancer increased by 181.86%. The incidence rates of thyroid cancer showed an increase in females but a decrease in males. In 2013, 4 974 people (2 292 men and 2 682 women) died of thyroid cancer, with an increase of 1 810 patients, compared with the figures in 1990. The mortality rate of thyroid cancer in 2013 decreased by 14.29%, compared with the figures in 1990. The mortality rate of thyroid cancer decreased in females while the incidence rate in males showed an increase. The incidence rates increased with age in females, reaching a peak at the 50-54 years old group. The mortality rate of thyroid cancer increased with age. The DALY, YLL and YLD due to thyroid cancer appeared as 13.35, 11.42 and 1.93 ten thousand person years, respectively, in 2013. Between 1990 to 2013, the age-standardized rates on DALY, YLL and YLD decreased from 10.33/100 000 to 8.84/100 000, from 9.60/100 000 to 7.61/100 000 and increased from 0.72/100 000 to 1.23/100 000, respectively. In 2013 the top three incidence rates were recorded in Qinghai, Xinjiang and Fujian provinces while the lowest was in Tibet. Compared with those in 1990, the incidence rates increased in all the provinces except for Tianjin. The top three high mortality rates were recorded in Qinghai, Hong Kong and Fujian and the lowest was also in Tibet. The mortality rates increased in five provinces. CONCLUSIONS Compared with those in 1990, the incidence of thyroid cancer increased, but the mortality decreased in 2013. Although significant decrease of DALY due to thyroid cancer was seen in 2013, the YLD burden was still increasing.
Collapse
Affiliation(s)
- S Cong
- Division of Cancer Control and Prevention, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - L W Fang
- Division of Cancer Control and Prevention, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - H L Bao
- Division of Cancer Control and Prevention, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y J Feng
- Division of Cancer Control and Prevention, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - N Wang
- Division of Cancer Control and Prevention, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - P Yin
- Division of Vital Statistics and Death Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y C Li
- Division of Integrated Prevention and Evaluation, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - X N Duan
- Peking University First Hospital, Beijing 100034, China
| | - M G Zhou
- National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| |
Collapse
|